Marinus Pharmaceuticals is covered by the following analysts.
| Firm |
Analyst |
| Cantor Fitzgerald |
Charles C. Duncan, PhD |
| Jefferies |
Andrew Tsai |
| Ladenburg Thalmann |
Michael Higgins |
| Oppenheimer |
Jay Olson |
| H.C. Wainwright & Co |
Douglas Tsao |
| JMP Securities |
Jason N. Butler, PhD |
| RBC |
Brian Abrahams, MD |
| RW Baird |
Brian Skorney |
| SVB Securities |
Marc Goodman |
| TD Cowen |
Joseph Thome |
| Truist |
Joon Lee |
Marinus Pharmaceuticals, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Marinus Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Marinus Pharmaceuticals, Inc. or its management. Marinus Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.